Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?
Ian D HaySuneetha KaggalGeoffrey B ThompsonPublished in: European thyroid journal (2022)
In a 5-decade experience, RRA administered postoperatively to stage I APTC patients did not reduce either CSM or TRR and should probably not be indicated when such patients undergo potentially curative BT.